tiprankstipranks
Advertisement
Advertisement

SE:SOBI Stock Latest News

RatingsKapoor Reiterates Buy on Sobi, Lifts Pozdeutinurad Success Odds and Raises 12-Month Price Target to SEK550 on Strong Phase 3 Gout Data
4d ago
PremiumCompany Announcements
Sobi Posts Positive Phase 3 Data for Gout Drug Pozdeutinurad
4d ago
Swedish Orphan Biovitrum initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Swedish Orphan Biovitrum initiated with a Buy at H.C. Wainwright
19d ago
PremiumCompany Announcements
Sobi AGM Backs Board, Incentive Plans and New Share Issue Mandate
20d ago
PremiumCompany Announcements
Sobi posts strong Q1 2026 as launches and pipeline deals power growth
28d ago
PremiumPre-Earnings0MTD Upcoming Earnings Report: What to Expect?
30d ago
Sobi Calls 2026 AGM With In-Person and Postal Voting Options
Premium
Company Announcements
Sobi Calls 2026 AGM With In-Person and Postal Voting Options
2M ago
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
Premium
The Fly
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
3M ago
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
PremiumThe Fly
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
3M ago
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
PremiumThe Fly
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
3M ago
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
PremiumCompany Announcements
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
3M ago
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
PremiumThe Fly
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
3M ago
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
PremiumCompany AnnouncementsSobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
4M ago
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
4M ago
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
Premium
Company Announcements
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
4M ago
PremiumCompany Announcements
Sobi Advances Gamifant After Positive Phase 2a Data in Interferon-Gamma–Driven Sepsis
5M ago
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
PremiumCompany Announcements
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
5M ago
Helena Saxon Resigns from Sobi Board of Directors
PremiumCompany Announcements
Helena Saxon Resigns from Sobi Board of Directors
7M ago
Sobi Reports Strong Q3 2025 Growth and Strategic Portfolio Expansion
PremiumCompany Announcements
Sobi Reports Strong Q3 2025 Growth and Strategic Portfolio Expansion
7M ago
Sobi Revises 2025 Outlook Following Strong Q3 Performance
PremiumCompany AnnouncementsSobi Revises 2025 Outlook Following Strong Q3 Performance
7M ago
Sobi Increases Common Shares and Votes
Premium
Company Announcements
Sobi Increases Common Shares and Votes
8M ago
Sobi Announces Increase in Shares and Votes to Support Long-term Incentive Programs
Premium
Company Announcements
Sobi Announces Increase in Shares and Votes to Support Long-term Incentive Programs
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >